{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T11:53:22Z","timestamp":1782474802812,"version":"3.54.5"},"reference-count":52,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2016,8,23]]},"DOI":"10.3233\/jad-151097","type":"journal-article","created":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T14:35:30Z","timestamp":1471358130000},"page":"383-395","source":"Crossref","is-referenced-by-count":46,"title":["A Decade of Cerebrospinal Fluid Biomarkers for Alzheimer\u2019s Disease in Belgium"],"prefix":"10.1177","volume":"54","author":[{"given":"Charisse","family":"Somers","sequence":"first","affiliation":[{"name":"Reference Center for Biological Markers of Dementia (BIODEM), Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Struyfs","sequence":"additional","affiliation":[{"name":"Reference Center for Biological Markers of Dementia (BIODEM), Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joery","family":"Goossens","sequence":"additional","affiliation":[{"name":"Reference Center for Biological Markers of Dementia (BIODEM), Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellis","family":"Niemantsverdriet","sequence":"additional","affiliation":[{"name":"Reference Center for Biological Markers of Dementia (BIODEM), Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Luyckx","sequence":"additional","affiliation":[{"name":"Reference Center for Biological Markers of Dementia (BIODEM), Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"De Roeck","sequence":"additional","affiliation":[{"name":"Reference Center for Biological Markers of Dementia (BIODEM), Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"De Roeck","sequence":"additional","affiliation":[{"name":"Reference Center for Biological Markers of Dementia (BIODEM), Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"De Vil","sequence":"additional","affiliation":[{"name":"Laboratory of Neurobiology, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Cras","sequence":"additional","affiliation":[{"name":"Laboratory of Neurobiology, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium"},{"name":"Department of Neurology, Antwerp University Hospital, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Martin","sequence":"additional","affiliation":[{"name":"Biobank, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter-Paul","family":"De Deyn","sequence":"additional","affiliation":[{"name":"Reference Center for Biological Markers of Dementia (BIODEM), Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium"},{"name":"Department of Neurology and Memory Clinic, Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken, Antwerp, Belgium"},{"name":"Biobank, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bjerke","sequence":"additional","affiliation":[{"name":"Reference Center for Biological Markers of Dementia (BIODEM), Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiaan","family":"Engelborghs","sequence":"additional","affiliation":[{"name":"Reference Center for Biological Markers of Dementia (BIODEM), Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium"},{"name":"Department of Neurology and Memory Clinic, Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken, Antwerp, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-151097_ref1","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipient Alzheimer\u2019s disease in patients with mild cognitive impairment: A follow-up study","volume":"5","author":"Hansson","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-151097_ref2","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.neurobiolaging.2007.02.016","article-title":"Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia","volume":"29","author":"Engelborghs","year":"2008","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-151097_ref3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1373\/clinchem.2009.130518","article-title":"Amyloid-(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease","volume":"56","author":"Mulder","year":"2010","journal-title":"Clin Chem"},{"key":"10.3233\/JAD-151097_ref4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jama.2009.1064","article-title":"CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment","volume":"302","author":"Mattsson","year":"2009","journal-title":"JAMA"},{"key":"10.3233\/JAD-151097_ref5","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1212\/WNL.52.8.1555","article-title":"Improved discrimination of AD patients using \u03b2-amyloid(1-42) and tau levels in CSF","volume":"52","author":"Hulstaert","year":"1999","journal-title":"Neurology"},{"key":"10.3233\/JAD-151097_ref6","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S1474-4422(09)70139-5","article-title":"Prevalence and prognostic value of CSF markers of Alzheimer\u2019s disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: A prospective cohort study","volume":"8","author":"Visser","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-151097_ref7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","article-title":"Cerebrospinal fluid and plasma biomarkers in Alzheimer disease","volume":"6","author":"Blennow","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-151097_ref8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3233\/JAD-2012-121246","article-title":"Comparison of two analytical platforms for the clinical qualification of Alzheimer\u2019s disease biomarkers in pathologically-confirmed dementia","volume":"33","author":"Le Bastard","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-151097_ref9","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-151097_ref10","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer\u2019s disease: The IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-151097_ref11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2018s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-151097_ref12","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s13760-014-0423-7","article-title":"Clinical utility and applicability of biomarker-based diagnostic criteria for Alzheimer\u2019s disease: A BeDeCo survey","volume":"115","author":"Bier","year":"2015","journal-title":"Acta Neurol Belg"},{"key":"10.3233\/JAD-151097_ref13","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/j.neurobiolaging.2008.10.017","article-title":"Added diagnostic value of CSF biomarkers in differential dementia diagnosis","volume":"31","author":"Le Bastard","year":"2010","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-151097_ref14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fneur.2015.00138","article-title":"Cerebrospinal fluid P-Tau181P: Biomarker for improved differential dementia diagnosis","volume":"6","author":"Struyfs","year":"2015","journal-title":"Front Neurol"},{"key":"10.3233\/JAD-151097_ref15","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.neurol.2013.07.024","article-title":"Clinical indications for analysis of Alzheimer\u2019s disease CSF biomarkers","volume":"169","author":"Engelborghs","year":"2013","journal-title":"Rev Neurol (Paris)"},{"key":"10.3233\/JAD-151097_ref16","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3233\/JAD-142103","article-title":"Overdiagnosing vascular dementia using structural brain imaging for dementia work-up","volume":"45","author":"Niemantsverdriet","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-151097_ref17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jns.2012.08.003","article-title":"The role of CSF biomarkers in the diagnostic work-up of mixed vascular-degenerative dementia","volume":"322","author":"Engelborghs","year":"2012","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-151097_ref18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.3233\/JAD-151097_ref19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2377-6-25","article-title":"Impact of the clinical context on the 14-3-3 test for diagnosis of sporadic CJD","volume":"6","author":"Cuadrado-Corrales","year":"2006","journal-title":"BMC Neurol"},{"key":"10.3233\/JAD-151097_ref20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ana.410430109","article-title":"Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease","volume":"43","author":"Zerr","year":"1998","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-151097_ref21","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1136\/jnnp.74.9.1210","article-title":"A prospective study of CSF markers in 250 patients with possible Creutzfeldt-Jakob disease","volume":"74","author":"Van Everbroeck","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-151097_ref22","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/jnnp.2003.032037","article-title":"14-3-3\u03b3-isoform detection distinguishes sporadic Creutzfeldt-Jacob disease from other dementias","volume":"76","author":"Van Everbroeck","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-151097_ref23","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.3233\/JAD-140405","article-title":"Depression in mild cognitive impairment is associated with progression to Alzheimer\u2019s disease: A longitudinal study","volume":"42","author":"Van der Mussele","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-151097_ref24","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jalz.2013.01.010","article-title":"CSF biomarker variability in the Alzheimer\u2019s Association quality control program","volume":"9","author":"Mattsson","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-151097_ref25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging\u2013Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: A practical approach","volume":"123","author":"Montine","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-151097_ref26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00401-007-0237-2","article-title":"Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: Consensus of the Consortium for Frontotemporal Lobar Degeneration","volume":"114","author":"Cairns","year":"2007","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-151097_ref27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00401-011-0845-8","article-title":"A harmonized classification system for FTLD-TDP pathology","volume":"122","author":"Mackenzie","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-151097_ref28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-009-0612-2","article-title":"Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: An update","volume":"119","author":"Mackenzie","year":"2009","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-151097_ref29","volume-title":"Neuropathology of Dementing Disorders","author":"Markesbery","year":"1998"},{"key":"10.3233\/JAD-151097_ref30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrneurol.2014.232","article-title":"Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases","volume":"11","author":"Ll\u00e9o","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-151097_ref31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jns.2014.07.015","article-title":"Assessment of CSF A\u03b242 as an aid to discriminating Alzheimer\u2019s disease from other dementias and mild cognitive impairment: A meta-analysis of 50 studies","volume":"345","author":"Tang","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-151097_ref32","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00415-010-5738-6","article-title":"Tau and 14-3-3 of genetic and sporadic Creutzfeldt\u2013Jakob disease patients in Israel","volume":"258","author":"Meiner","year":"2010","journal-title":"J Neurol"},{"key":"10.3233\/JAD-151097_ref33","first-page":"536538","article-title":"Cerebrospinal fluid biomarkers for dementia with Lewy bodies","volume":"2010","author":"Mukaetova-Ladinska","year":"2010","journal-title":"Int J Alzheimers Dis"},{"key":"10.3233\/JAD-151097_ref34","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1093\/brain\/awm136","article-title":"No association of CSF biomarkers with APOE\u025b4, plaque and tangle burden in definite Alzheimer\u2019s disease","volume":"130","author":"Engelborghs","year":"2007","journal-title":"Brain"},{"key":"10.3233\/JAD-151097_ref35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3233\/JAD-122176","article-title":"Amyloid pathology influences A\u03b21-42 cerebrospinal fluid levels in dementia with Lewy bodies","volume":"35","author":"Slaets","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-151097_ref36","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3233\/JAD-130107","article-title":"Cerebrospinal fluid A\u03b21-40 improves differential dementia diagnosis in patients with intermediate P-tau181P levels","volume":"36","author":"Slaets","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-151097_ref37","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2174\/156720510791383796","article-title":"The cerebrospinal fluid amyloid \u03b242\/40 ratio in the differentiation of Alzheimer\u2019s disease from non-Alzheimer\u2019s dementia","volume":"7","author":"Spies","year":"2010","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-151097_ref38","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3233\/JAD-131838","article-title":"Additional use of Abeta42\/Abeta40 ratio with cerebrospinal fluid biomarkers P-Tau and Abeta42 increases the level of evidence of Alzheimer\u2019s disease pathophysiological proces in routine practice","volume":"41","author":"Sauv\u00e9e","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-151097_ref39","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3233\/JAD-140771","article-title":"Amyloid-\u03b2 42\/40 cerebrospinal fluid concentration ratio in the diagnosis of Alzheimer\u2019s disease: Validation of two novel assays","volume":"43","author":"Lewczuk","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-151097_ref40","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2015.4668","article-title":"Prevalence of cerebral amyloid pathology in persons without dementia","volume":"313","author":"Jansen","year":"2015","journal-title":"JAMA"},{"key":"10.3233\/JAD-151097_ref41","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3233\/JAD-141986","article-title":"Diagnostic accuracy of cerebrospinal fluid amyloid-\u03b2 isoforms for early and differential dementia diagnosis","volume":"45","author":"Struyfs","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"S","key":"10.3233\/JAD-151097_ref42","first-page":"298","article-title":"Increased CSF \u03b1-synuclein levels in Alzheimer\u2019s disease: Correlation with tau levels.S290-S","volume":"10","author":"Slaets","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-151097_ref43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2217\/BMM.14.105","article-title":"The utility of \u03b1-synuclein as biofluid marker in neurodegenerative diseases: A systematic review of the literature","volume":"10","author":"Simonsen","year":"2016","journal-title":"Biomark Med"},{"key":"10.3233\/JAD-151097_ref44","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40478-015-0195-1","article-title":"TDP-43 as a possible biomarker for frontotemporal lobar degeneration: A systematic review of existing antibodies","volume":"3","author":"Goossens","year":"2015","journal-title":"Acta Neuropathol Commun"},{"key":"10.3233\/JAD-151097_ref45","first-page":"610613","article-title":"Lessons from multicenter studies on CSF biomarkers for Alzheimer\u2019s disease","volume":"2010","author":"Mattsson","year":"2010","journal-title":"Int J Alzheimers Dis"},{"key":"10.3233\/JAD-151097_ref46","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3233\/JAD-150953","article-title":"Diagnostic impact of cerebrospinal fluid biomarker variability in Alzheimer\u2019s disease","volume":"51","author":"Niemantsverdriet","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-151097_ref47","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1373\/clinchem.2014.236679","article-title":"Importance and impact of preanalytical variables on Alzheimer disease biomarker concentrations in cerebrospinal fluid","volume":"61","author":"Le Bastard","year":"2015","journal-title":"Clin Chem"},{"key":"10.3233\/JAD-151097_ref48","first-page":"986310","article-title":"Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid","volume":"2010","author":"Bjerke","year":"2010","journal-title":"Int J Alzheimers Dis"},{"key":"10.3233\/JAD-151097_ref49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2014.03.003","article-title":"The clinical use of cerebrospinal fluid biomarker testing for Alzheimer\u2019s disease diagnosis: A consensus paper from the Alzheimer\u2019s Biomarkers Standardization Initiative","volume":"10","author":"Molinuevo","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-151097_ref50","doi-asserted-by":"crossref","first-page":"386-395.e6","DOI":"10.1016\/j.jalz.2011.05.2243","article-title":"The Alzheimer\u2019s Association external quality control program for cerebrospinal fluid biomarkers","volume":"7","author":"Mattsson","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-151097_ref51","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jalz.2011.07.004","article-title":"Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer\u2019s disease diagnosis: A consensus paper from the Alzheimer\u2019s Biomarkers Standardization Initiative","volume":"8","author":"Vanderstichele","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-151097_ref52","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1515\/cclm-2015-0733","article-title":"Assessing the commutability of reference material formats for the harmonization of amyloid beta measurements","volume":"54","author":"Bjerke","year":"2016","journal-title":"Clin Chem Lab Med"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-151097","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:03:29Z","timestamp":1777370609000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-151097"}},"subtitle":[],"editor":[{"given":"Daniela","family":"Galimberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,8,23]]},"references-count":52,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-151097","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,23]]}}}